Newronika

Series-B+
newronika.com Biotech & Healthcare Cologno Monzese, Italy
Total Funding $15.9M
Latest Round $15.9M Series-B+
Last Announced Feb 13, 2025
Investors 7 Backers
Decision Makers 6 Verified

About Newronika

Newronika develops adaptive deep brain stimulation systems that respond to the brain's own signals. CE-marked αDBS therapy — precision neuromodulation for Parkinson's and beyond.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-B+
Global Headquarters Cologno Monzese, Italy
Tracked Since Oct 1, 2026

Web & Domain Identity

Official Website newronika.com
Domain Registered Date Jun 30, 2008

Social & Network Presence

X / Twitter Profile @newronika (90 followers) Created on Nov 2013
LinkedIn Corporate Not linked

Company Milestones & Timeline

3 Events
  1. Capital Raise

    Raised $15,880,000 · Series-B+

    startupintros.com

  2. Milestone

    X account created (@newronika)

    90 followers

  3. Milestone

    Website domain registered

    newronika.com

Investors & Backers

7
ENEA Tech e Biomedical
European Innovation Council Fund
F3F
Indaco Venture Partners
Innogest Capital
TNBT Capital
Wille Finance

Funding History

1 Round
Series-B+ · Feb 13, 2025

Founders & Leadership

4

Alberto Priori

Co-Founder, Scientific Advisory Board Chairman

Work email & phone locked Unlock →

Lorenzo Rossi

Co-Founder, CEO & CTO

Work email & phone locked Unlock →

Lothar Krinke

CEO

Work email & phone locked Unlock →

Sara Marceglia

Co-Founder, Associate Professor

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts